It has been previously demonstrated that the combination of CTC number and CEA levels could provide a more accurate prognosis in CRC patients, due to the range of factors normally affecting CEA levels in vivo [56,57]. This evidence concerns the gene CEACAM5 and colorectal carcinoma.